ICU Medical, Inc.
ICUI
$159.58
$2.321.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -8.97% | -10.88% | -6.33% | -0.84% | 2.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.97% | -10.88% | -6.33% | -0.84% | 2.96% |
| Cost of Revenue | -13.65% | -14.76% | -9.51% | -6.17% | -2.18% |
| Gross Profit | -0.60% | -3.71% | -0.33% | 10.04% | 13.65% |
| SG&A Expenses | -3.62% | -2.47% | -2.12% | -0.99% | 2.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.36% | -10.97% | -7.12% | -4.50% | -0.71% |
| Operating Income | 16.34% | -9.17% | 12.25% | 181.65% | 214.95% |
| Income Before Tax | -105.45% | 123.64% | 104.80% | 126.84% | 116.17% |
| Income Tax Expenses | -158.57% | -168.82% | -95.28% | 38,183.51% | 291.74% |
| Earnings from Continuing Operations | 181.43% | 149.46% | 100.62% | 93.37% | 47.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 181.43% | 149.46% | 100.62% | 93.37% | 47.80% |
| EBIT | 16.34% | -9.17% | 12.25% | 181.65% | 214.95% |
| EBITDA | 4.13% | -6.94% | -2.16% | 23.23% | 24.75% |
| EPS Basic | 179.33% | 148.97% | 100.59% | 93.27% | 47.92% |
| Normalized Basic EPS | 137.89% | 115.54% | 384.65% | 168.34% | 142.45% |
| EPS Diluted | 177.20% | 148.22% | 100.45% | 92.95% | 47.54% |
| Normalized Diluted EPS | 137.14% | 114.13% | 384.38% | 168.30% | 142.49% |
| Average Basic Shares Outstanding | 1.04% | 0.94% | 1.04% | 1.20% | 1.27% |
| Average Diluted Shares Outstanding | 1.45% | 1.43% | 1.10% | 1.27% | 1.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |